Company: PACB
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001299130-25-000090
Chunk: 88

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 88
---
public informationto affect the value of executive compensation.

#### Compensation Committee Report
This report of the Compensation Committee shall not be deemed to be “soliciting material” or to otherwise be considered “filed” with the SEC, nor shall such information be incorporated by reference into any future filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act except to the extent that the Company specifically incorporates it by reference into such filing.

The Compensation Committee has reviewed and discussed with management the disclosures contained in the above section entitled “Compensation Discussion and Analysis”. Based on this review and discussion, the Compensation Committee recommended to the Board of Directors that the section entitled “Compensation Discussion and Analysis” be included in this Proxy Statement for the Annual Meeting.

#### Members of the Compensation Committee
<div align='center'>William Ericson (Chair)

Marshall Mohr

John F. Milligan, Ph.D.

Kathy Ordoñez</div>

| 2025 Proxy Statement |     | 65 |

TABLE OF CONTENTS

#### Compensation Risk Assessment
At the direction of the Compensation Committee, in conjunction with a compensation consultant’s assessment, we reviewed our compensation practices and policies during 2024 and our findings were presented to the Compensation Committee for consideration. After consideration of the information presented, the Compensation Committee has concluded that our compensation programs, including our executive compensation program, do not encourage excessive risk taking by our executives or other employees. As a result, the Compensation Committee believes that our employee compensation program does not create risk that is reasonably likely to have a material adverse effect on our Company.

Compensation Committee Interlocks and Insider Participation

None of our Compensation Committee members is or has been one of our officers or employees in 2024.

There were not any director interlocks among members of our Board of Directors in 2024.

| 2025 Proxy Statement |     | 66 |

TABLE OF CONTENTS

| Executive Compensation Tables |

#### Summary Compensation Table
The following table provides information regarding the compensation of our NEOs for the years ended December 31, 2024, 2023, and 2022, respectively:

<div align='center'>Summary Compensation Table for Fiscal Years 2024, 2023 and 2022</div>

| Name and Principal Position           |     | Year |     | Salary ($) |         |     | Bonus ($) |         |     |     |     | Stock Awards 
 ($)(1)       |           |     | Option Awards 
 ($